ÌÇÐÄvlog¹Ù·½Èë¿Ú

A new study by ÌÇÐÄvlog¹Ù·½Èë¿Ú researchers shows how light and strained ruthenium-based drugs may be more effective at fighting cancer cells and less toxic to healthy cells than a similar and widely used drug.

Leading experts in chemistry involving metals and proteins will be the featured speakers at the symposium Friday, May 4, on UK's campus.